Steve Bellon

Steve Bellon

Company: Foghorn Therapeutics

Job title: Chief Scientific Officer


Advancement of Degraders Targeting Key Chromatin Regulators Involved in Disease/Oncology 9:30 am

Progressing selective degradation of CBP and EP300 and their respective preclinical programs Highlighting planned expansion of Foghorn TPD platform and portfolioRead more

day: Day 1

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.